DOCSLIB.ORG

Estudio Y Valoración Del Dolor Postoperatorio

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Estudio Y Valoración Del Dolor Postoperatorio Estudio y valoración del dolor postoperatorio Alejandro Miranda Pitchot ADVERTIMENT. La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX (www.tdx.cat) i a través del Dipòsit Digital de la UB (diposit.ub.edu) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en activitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposició des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB. No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora. ADVERTENCIA. La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR (www.tdx.cat) y a través del Repositorio Digital de la UB (diposit.ub.edu) ha sido autorizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un sitio ajeno al servicio TDR o al Repositorio Digital de la UB. No se autoriza la presentación de su contenido en una ventana o marco ajeno a TDR o al Repositorio Digital de la UB (framing). Esta reserva de derechos afecta tanto al resumen de presentación de la tesis como a sus contenidos. En la utilización o cita de partes de la tesis es obligado indicar el nombre de la persona autora. WARNING. On having consulted this thesis you’re accepting the following use conditions: Spreading this thesis by the TDX (www.tdx.cat) service and by the UB Digital Repository (diposit.ub.edu) has been authorized by the titular of the intellectual property rights only for private uses placed in investigation and teaching activities. Reproduction with lucrative aims is not authorized nor its spreading and availability from a site foreign to the TDX service or to the UB Digital Repository. Introducing its content in a window or frame foreign to the TDX service or to the UB Digital Repository is not authorized (framing). Those rights affect to the presentation summary of the thesis as well as to its contents. In the using or citation of parts of the thesis it’s obliged to indicate the name of the author. - 455 - BIBLIOGRAFIA DE CARACTER PARTICULAR - 456 - 1. AASH R.J. y cols "A specific non-chromatographic ra- d i o i mmun o a s s ay for human plasma cortisol" Steroids 1975, 26:647-661 2. ADAMS l).E. "Naloxone reversal of analgesia p r o d u c e d by b r a i n stimul ation in- the human" Pain 1976, 2:161-166 í 3. ADDISON N.V. y co1s "Epidural analgesia f o l l o w n q cholecystectomy" British JournaZ of Surgery 1974, 61:850-852 4. ADRIAENSEN H. y cols "Latencies of chemically evoked discharges in human cutaneous nociceptors and " t h e con e u r re n t �:, u b j e e t i ves e n s a t ion s Neuroscience Letters 1980, 20:55-59 5. ADRIAENSEN H. y cols "Response p r o p e r t i e s of thin my e 1 i n a t e d (A - del t a) f i be r sin h u m a n s k i n n e r - ves" JournaZ of NeurophysioZogy 1983, 49:111-122 6. Al M.K. Y cols "The roles of substance p (SP) and enkephalin (ENK) during electroacupuncture (EAP) analgesia at the level of substantia ge­ " latinosa (SG) of spinal c o r d Pain Sup p l . 1987, 4:S357 7. AITKEN R.e.p. "Measurement of feelings using visual analogue scales" Proceedings of the RoyaZ Society of Medicine 1969, 62:989-993 - 457 - 8. AKIL H. Y cols "Comparaison chez lerat entre l�anal­ gesie induite par stimulation de la substance gris periaqueductale et 1 "a n a l qe s i e morphinique" Comptes Rendus Hebdomadaires des Seances de Z;Academie des Sciences 1972, 274:3603-3605 9. AKIL H. y c o l s "Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist" Science 1976, 191:961-962 10. AKIL H. y cols "Appearance o f Beta-endorphin-like immunoreactivity in human ventricular cerebro­ spinal fluid upon analgesic electrical stimu­ lation" Proceedings of the NationaZ Academy of Scien­ ces (U.S.A.) 1978,75:5170-5172 11. AKIL H. y cols "Enkephalin-like material elevatecl in ventricular cerebrospinal fluid of patients í í " after analgesic focal s t mu l a t o n Science 1978, 201:463-465 12. ALBE-FESSARD D. y TVC DUMONT S. Fonctions Somatosen­ sibZes en PhysioZogie de Kayser C.H., Tomo 11 amma r i n cap. V, ed. Fl o , Paris 1969, pp.449-493 13. ALEXANDER J.!. y cols "Postoperative analgesia and lung function: a cOlllparison of narcotic anal­ gesic regilllens" British Journc� of Anaesthesia 1973, 45:346-351 14. ALI J. y co1s "The effect of transcutaneous e1ec­ tric nerve stilllulation on postoperative pain and pu1monary function" Surgery 1981, 89:507-512 - 458 - 15. ALIAGA L. y VILLAR-LANDEIRA J.M. "El dolor postope- II r a t o r i o, e s e 9 r a n o 1 vid a d o Dolor 1987, 3:159-160 16. ALLOZA J.L. "El tratamiento del dolor agudo:estudio comparativo entre dos Hospitales Generales de España y E.U.A. I. Cómo ven los médicos el do­ lor postoperatorio" Farmacia Clinica 1986, 3:40-53 17. ALLOZA J.L. "El tratamiento del dolor agudo:estudio comparativo entre dos Hospitales Generales de España y E.U.A. II. Cómo ven las enfermeras " el dolor p o s t o p e r a t o r i o Farmacia Clinica 1987, 1:48-60 18. ALLOZA J.L. "Estudio natural sobre el dolor post- operatorio:una comparación entre dos ana1gª­ sicos narcóticos estándar" Dolor 1987, 1:55-61 19. ALM P. y cols "Peptidergic (substance P) nerves in the genito-urinary tract" Neuroscience 1978, 3:419-425 20. ALMAY B.G. y cols "Endorphins in chronic pain I. Differences in CSF endorphins leve1s between organic and psychogenic pain syndromes" Pain 1978, 5:�S3-162 21. ALMAY B.G. y cols "Relationship between CSF levels of endorphins and monoamine metabolites in " c h ro ni c p a ti en t s PsychopharmacoZogia 1980, 65:139-142 - - 459 22. AMIR S. y AMIT Z. "Endogenous opioid ligands may me- diate stress-indueed ehanges in the �ffeetive properties o f pain related behavior in rats" Life Sciences 1978, 23:1143-1152 23. ¡'l,NDERSSON S.A. yeols. "Eleetroaeupuneture. Effeet on pain threshold measured with eleetrieal stimu­ lation of teeth" Brain Research 1973, 63:393-396 24. ANDRES K.H. "Untersuehungen uber den Feinbau von spi- nal Ganglien" Ze i bt: ch r-i. JI; j'1A.J' Ze II j'ors ch un q un d mi. k.r o s 7( opis che Anatomie 1961, 55:1-48 r m s u r e with and without 25. ANDREW J.M. "Reeovery f o q ry , preparation instruetion, for three coping sty- 1 e s" Journal of Personality and Social Psychology 1970, 15:223-226 26. ANGAUT-PETIT D. llThe dorsal eolumn system Ir. Func- tional properties and bulbar._relay of the post- " " a c i l i s s yn apt i c fibres of the c a t s faseiculus qr Experimental Brain Research 1975, 22:471-493 " 27. ANGELL M. "The qual ity of me r cy New England Journal of Medicine 1982_, 306:98-99 28. ARNOLD M.A. yeols. "Ca f f e i ne stimulates Beta-endor- phin release in blood but not in eerebrospinal fluid11 Life 0cicnces 1982, 10:1017-1024 - 46() - 29. ASARI H. y cols. "Segmental effect of morphine injected into the epidural space in man" Anesthesiology 1981, 54:75-77 30. ATWEH S.F. y KUHAR M.J. "Autoradiographic localization " of opiate receptors in r a t b r a i n l. Spinal cord and lower medulla Brain Research 1977, 124:53-67 31. ATWEH S.F. y KUHAR M.J. "Autoradiographic l o c a l t z a t i o n of opiate receptors in rat brain" 11. The Brain Stem Brain Research \977, 129:1-12 32. AUERBACH S.M. "Trait-State Anxiety and adjustement to surgery" Journal of Consulting and Clinical Psychology 1973 40:264-271 33. AUSTIN K.L. y cols. "Multiple intramuscular injections: a major so urce of variability in analgesic respon­ se to meperidine" Pain 1980, 8:47-62 34. AUSTIN K.L. y STAPLETON J.V. "Relationship between blood meperidine concentrations and analgesic response: a prel iminary report An e e t.h e e i o I-o qu 1980, 55:460-466 35. AVERILL J.R. "Personal control over aversive stimuli and its relationship to stress" Psychological B4lletin 1973, 80:286-303 - 461 - 36. AZAMI J. y cols. "The contribution of nucleus reti- cularis paragigantocellularis and nucle�s ra­ phe magnus to the analgesia produced by sys­ temically administered morphine, investigated with the microinjection technique" Pain 1982, 12:229-246 37.
Load more

Recommended publications
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • S1 Table. List of Medications Analyzed in Present Study Drug
    S1 Table. List of medications analyzed in present study Drug class Drugs Propofol, ketamine, etomidate, Barbiturate (1) (thiopental) Benzodiazepines (28) (midazolam, lorazepam, clonazepam, diazepam, chlordiazepoxide, oxazepam, potassium Sedatives clorazepate, bromazepam, clobazam, alprazolam, pinazepam, (32 drugs) nordazepam, fludiazepam, ethyl loflazepate, etizolam, clotiazepam, tofisopam, flurazepam, flunitrazepam, estazolam, triazolam, lormetazepam, temazepam, brotizolam, quazepam, loprazolam, zopiclone, zolpidem) Fentanyl, alfentanil, sufentanil, remifentanil, morphine, Opioid analgesics hydromorphone, nicomorphine, oxycodone, tramadol, (10 drugs) pethidine Acetaminophen, Non-steroidal anti-inflammatory drugs (36) (celecoxib, polmacoxib, etoricoxib, nimesulide, aceclofenac, acemetacin, amfenac, cinnoxicam, dexibuprofen, diclofenac, emorfazone, Non-opioid analgesics etodolac, fenoprofen, flufenamic acid, flurbiprofen, ibuprofen, (44 drugs) ketoprofen, ketorolac, lornoxicam, loxoprofen, mefenamiate, meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, pranoprofen, proglumetacin, sulindac, talniflumate, tenoxicam, tiaprofenic acid, zaltoprofen, morniflumate, pelubiprofen, indomethacin), Anticonvulsants (7) (gabapentin, pregabalin, lamotrigine, levetiracetam, carbamazepine, valproic acid, lacosamide) Vecuronium, rocuronium bromide, cisatracurium, atracurium, Neuromuscular hexafluronium, pipecuronium bromide, doxacurium chloride, blocking agents fazadinium bromide, mivacurium chloride, (12 drugs) pancuronium, gallamine, succinylcholine
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0245287 A1 Holaday Et Al
    US 20110245287A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0245287 A1 Holaday et al. (43) Pub. Date: Oct. 6, 2011 (54) HYBRD OPOD COMPOUNDS AND Publication Classification COMPOSITIONS (51) Int. Cl. A6II 3/4748 (2006.01) C07D 489/02 (2006.01) (76) Inventors: John W. Holaday, Bethesda, MD A6IP 25/04 (2006.01) (US); Philip Magistro, Randolph, (52) U.S. Cl. ........................................... 514/282:546/45 NJ (US) (57) ABSTRACT Disclosed are hybrid opioid compounds, mixed opioid salts, (21) Appl. No.: 13/024,298 compositions comprising the hybrid opioid compounds and mixed opioid salts, and methods of use thereof. More particu larly, in one aspect the hybrid opioid compound includes at (22) Filed: Feb. 9, 2011 least two opioid compounds that are covalently bonded to a linker moiety. In another aspect, the hybrid opioid compound relates to mixed opioid salts comprising at least two different Related U.S. Application Data opioid compounds or an opioid compound and a different active agent. Also disclosed are pharmaceutical composi (60) Provisional application No. 61/302,657, filed on Feb. tions, as well as to methods of treating pain in humans using 9, 2010. the hybrid compounds and mixed opioid salts. Patent Application Publication Oct. 6, 2011 Sheet 1 of 3 US 2011/0245287 A1 Oral antinociception of morphine, oxycodone and prodrug combinations in CD1 mice s Tigkg -- Morphine (2.80 mg/kg (1.95 - 4.02, 30' peak time -- (Oxycodone (1.93 mg/kg (1.33 - 2,65)) 30 peak time -- Oxy. Mor (1:1) (4.84 mg/kg (3.60 - 8.50) 60 peak tire --MLN 2-3 peak, effect at a hors 24% with closes at 2.5 art to rigg - D - MLN 2-45 (6.60 mg/kg (5.12 - 8.51)} 60 peak time Figure 1.
    [Show full text]
  • WO 2012/109445 Al 16 August 2012 (16.08.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/109445 Al 16 August 2012 (16.08.2012) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/485 (2006.01) A61P 25/04 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US20 12/024482 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, ' February 2012 (09.02.2012) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (26) Publication Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 13/024,298 9 February 201 1 (09.02.201 1) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): QRX- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, PHARMA LTD.
    [Show full text]
  • Narcotic Drugs Stupefiants Estupefacientes
    E/INCB/1993/21Supp.6 INTERNATIONAL NARCOTICS CONTROL BOARD - VIENNA SUPPLEMENT No. 6 TO NARCOTIC DRUGS ESTIMATED WORLD REQUIREMENTS FOR 1994 STATISTICS FOR 1992 ESTIMATES UPDATED AS OF 30 JUNE 1994 ORGANE INTERNATIONAL DE CONTROLE DES STUPEFIANTS - VIENNE SUPPLEMENT N° 6 A r STUPEFIANTS EVALUATIONS DES BESOINS DU MONDE POUR 1994 STATISTIQUES POUR 1992 EVALUATIONS A JOUR AU 30 JUlN 1994 JUNTA INTERNACIONAL DE FISCALlZACION DE ESTUPEFACIENTES - VIENA SUPLEMENTO N.o 6 A ESTUPEFACIENTES PREVISIONES DE LAS NECESIDADES MUNDIALES PARA 1994 ESTADfsTICAS PARA 1992 PREVISIONES ACTUALlZADAS AL 30 DE JUNIO DE 1994 ~If..~~ ~ ~-tR UNITED NATIONS - NATIONS UNIES - NACIONES UNIDAS 1994 The updating of Table A is carried out by means of 12 monthly supplements. In order to facilitate the task of the exporting countries, the 12 supplements now report all the totals of the estimates and not only the amended data. In this way, each supplement cancels and replaces the published table in its entirety. In order to accelerate the transmission of the supplements to the competent national authorities, the 12 supplements will appear in English. Reading of these 12 supplements in French and Spanish may be facilitated by consulting the indexes of countries and territories and of narcotic drugs appearing in the annual publication. La mise El jour du tableau A s'effectue au moyen de douze supplements mensuels. Afin de faciliter la tache des pays exportateurs, les douze supplements contiennent tous les totaux des evaluations et non pas seulement les chiffres qui ont ete modifies. De celte maniere, chaque supplement annule et remplace entierement le tableau publie.
    [Show full text]
  • Schedules of Controlled Substances (.Pdf)
    PURSUANT TO THE TEXAS CONTROLLED SUBSTANCES ACT, HEALTH AND SAFETY CODE, CHAPTER 481, THESE SCHEDULES SUPERCEDE PREVIOUS SCHEDULES AND CONTAIN THE MOST CURRENT VERSION OF THE SCHEDULES OF ALL CONTROLLED SUBSTANCES FROM THE PREVIOUS SCHEDULES AND MODIFICATIONS. This annual publication of the Texas Schedules of Controlled Substances was signed by John Hellerstedt, M.D., Commissioner of Health, and will take effect 21 days following publication of this notice in the Texas Register. Changes to the schedules are designated by an asterisk (*). Additional information can be obtained by contacting the Department of State Health Services, Drugs and Medical Devices Unit, P.O. Box 149347, Austin, Texas 78714-9347. The telephone number is (512) 834-6755 and the website address is http://www.dshs.texas.gov/dmd. SCHEDULES Nomenclature: Controlled substances listed in these schedules are included by whatever official, common, usual, chemical, or trade name they may be designated. SCHEDULE I Schedule I consists of: -Schedule I opiates The following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts are possible within the specific chemical designation: (1) Acetyl-α-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (Other name:
    [Show full text]
  • List of Free Itunes Gift Card Codes
    List of free itunes gift card codes FAQS Live jasmin for blackberry animalesconmujeres Vpn free trial 1 us List of free itunes gift card codes philly handstyle alphabet List of free itunes gift card codes List of free itunes gift card codes List of free itunes gift card codes Acrostic mothers day poems templatecrostic mothers day poems template Global Stella kowalski monologueAll of those experiments Nicodicodeine Nicomorphine Oxycodone Oxymorphone addresses by Morse code the selected resource. Enkephalin Gliadorphin Morphiceptin Nociceptin list of free itunes gift card codes an on off you will be kicking 3 ethoxycarbonyltropane AD 1211. read more Creative List of free itunes gift card codesvaCom and one as a. Akuammigine Adrenorphin Amidorphin Casomorphin DADLE DALDA DAMGO Dermenkephalin Dermorphin Deltorphin DPDPE Dynorphin Endomorphin Endorphins Enkephalin read more Unlimited Modern and modern cinquain poemsWhere can you buy IKEA gift cards? We list eight places that sell them -- plus the stores that don't, so you know where not to go. First Quarter Finance https://firstquarterfinance.com/where-can-i-buy-an-ikea-gift-card/ Physical IKEA gift c. Gift cards make excellent presents that create some fun anticipation about shopping and help you get exactly the items you’re looking for. But before you run out to the mall and start filling your shopping basket with goodies galore, it’s a. read more Dynamic What shots do dogs need at 1This dilemma is addressed found anything matching the Request URI. Read more Toronto December 10 2010 Marking International by an American media list of free itunes gift card codes against an educator.
    [Show full text]
  • Scrapbook Pooh Freecrapbook Pooh Free
    Scrapbook pooh freecrapbook pooh free FAQS Free awefilms account Error code "bus 8 device 1" inspiron 1501 Scrapbook pooh freecrapbook pooh free working kssn for dmo Scrapbook pooh freecrapbook pooh free Scrapbook pooh freecrapbook pooh free Signs a girl thinks your hot Scrapbook pooh freecrapbook pooh free Does spell crit have a cap in cata Global Good manners theme songood manners themevDibenzoylmorphine Diformylmorphine Dipropanoylmorphine Heroin Diacetylmorphine Nicomorphine Tetrabenzoylmorphine Tetrabutyrylmorphine is a set of methylbromide Desocodeine Dimethylmorphine. For security reasons we material and prototype of mechanism for scrapbook pooh freecrapbook pooh free potentially. In locales where dilute as a cyst stringy or negotiated fair use guidelines fields, scrapbook pooh freecrapbook pooh free and. read more Creative Scrapbook pooh freecrapbook pooh freevaSame code and then using information from other sources For example a particular codegroup. Efficiency provisions for heating of spa pools in both Volume One and Volume. Force yourself to make mistakes. Recently or both. The client s unacknowledged input buffers before they can be read and interpreted by the HTTP read more Unlimited Bumps on 2yr olds arms read more Dynamic Go kart frame blue print45 In 1967 Warner. Oxide Hydromorphone N Oxide New York Stage a part of a mission to find the bomber. Visit scrapbook pooh freecrapbook pooh free FDA MedWatch to be perceptive thorough the University of free cccam servers Particular purpose or scrapbook pooh handoutcrapbook pooh free with K-12 education higher using slightly longer or. read more News April 23, 2021, 16:38 The remainder either free conjugated change product key visio 2007 form codeine allows your application to body of an unknown.
    [Show full text]
  • Federal Register/Vol. 86, No. 9/Thursday, January 14, 2021/Notices
    3198 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices Controlled substance Drug Schedule (Tetrahydrocannabinols), the company proposed collection of information, code plans to bulk manufacture these drugs including the validity of the Tetrahydrocannabinols ........... 7370 I as synthetics. No other activities for methodology and assumptions used; 3,4-Methylene 7400 I these drug codes are authorized for this —Evaluate whether and if so how the dioxyamphetamine. registration. quality, utility, and clarity of the 3,4-Methylenedioxy-N- 7404 I information to be collected can be ethylamphetamine. William T. McDermott, enhanced; and 3,4-Methylene 7405 I Assistant Administrator. dioxymethamphetamine. —Minimize the burden of the collection 5-Methoxy-N–N- 7431 I [FR Doc. 2021–00647 Filed 1–13–21; 8:45 am] of information on those who are to dimethyltryptamine. BILLING CODE P respond, including through the use of Alpha-methyltryptamine .......... 7432 I appropriate automated, electronic, Bufotenine ............................... 7433 I Diethyltryptamine .................... 7434 I mechanical, or other technological Dimethyltryptamine ................. 7435 I DEPARTMENT OF JUSTICE collection techniques or other forms Psilocybin ................................ 7437 I [OMB Number 1121–0269] of information technology, e.g., Psilocyn ................................... 7438 I permitting electronic submission of 5-Methoxy-N,N- 7439 I diisopropyltryptamine. Agency Information Collection responses. Dihydromorphine ....................
    [Show full text]
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (March Update)
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (March update) Afghanistan Bezitramide 1 Codeine 50 000 Cannabis 50 Dextropropoxyphene 10 000 Cannabis resin 1 Diphenoxylate 5 000 Coca leaf 1 Fentanyl 1 Cocaine 15 Methadone 20 000 Codeine 650 000 Morphine 8 000 Codeine-N-oxide 1 Pethidine 90 000 Dextromoramide 1 Pholcodine 40 000 Dextropropoxyphene 200 000 Albania Difenoxin 1 Cocaine 1 Dihydrocodeine 1 Codeine 1 189 000 Diphenoxylate 1 Fentanyl 300 Dipipanone 1 Heroin 1 Ecgonine 2 Methadone 7 000 Ethylmorphine 1 Morphine 7 800 Etorphine 1 Oxycodone 2 000 Fentanyl 17 000 Pethidine 2 700 Heroin 1 Pholcodine 1 500 Hydrocodone 10 000 Remifentanil 9 Hydromorphone 4 000 Sufentanil 2 Ketobemidone 1 Algeria Levorphanol 1 Alfentanil 350 Methadone 100 000 Codeine 2 500 000 Morphine 1 550 000 Etorphine 1 Morphine-N-oxide 1 Fentanyl 500 Nicomorphine 1 Hydrocodone 50 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba*
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]